Exact Sciences Corporation (NASDAQ:EXAS) Moves -8.53%

Marco Green
January 14, 2018

Additionally, according to the most recent 13F filing from Exact Sciences Corporation (EXAS), there were 51 new positions totaling 1,749,221 shares of the company's stock. LLC now owns 2,356,706 shares of the medical research company's stock valued at $83,357,000 after purchasing an additional 875,527 shares during the last quarter. Exact Sciences Corp now has $6.32 billion valuation. The stock decreased 3.63% or $2 during the last trading session, reaching $53.06. 1,699,484 shares of the company's stock were exchanged, compared to its average volume of 1,930,000.

EXACT Sciences (NASDAQ:EXAS) traded up $1.10 on Thursday, reaching $55.06. It has outperformed by 441.54% the S&P500.

Green Valley Investors Llc decreased Unitedhealth Group Inc (NYSE:UNH) stake by 12,506 shares to 442,762 valued at $86.72 million in 2017Q3. Spark Investment Mgmt Ltd Liability reported 58,700 shares stake. Antipodean Advisors Llc who had been investing in Exact Sciences Corp for a number of months, seems to be bullish on the $6.30B market cap company. First Advsrs Limited Partnership accumulated 68,698 shares or 0.01% of the stock. It has outperformed by 56.14% the S&P500. Finally, Zacks Investment Research lowered shares of EXACT Sciences from a "buy" rating to a "hold" rating in a report on Thursday, November 2nd.

Aetna Inc. has a consensus outperform rating from 19 Wall Street analysts, and the number of shares now sold short amount to at least 0.84% of shares outstanding. The stock has "Buy" rating by Wells Fargo on Monday, October 2. The rating was maintained by Benchmark on Tuesday, October 31 with "Buy". The stock has a consensus rating of "Buy" and a consensus price target of $50.58. The rating was maintained by Leerink Swann with "Outperform" on Tuesday, October 31. Roth Capital downgraded the stock to "Neutral" rating in Thursday, February 25 report. (NYSE:C) on Sunday, July 16 with "Buy" rating.

Investors sentiment decreased to 1.01 in 2017 Q3. Its down 0.26, from 1.27 in 2017Q2.

Several other institutional investors have also bought and sold shares of EXAS. 44 funds opened positions while 77 raised stakes. Victory Cap holds 0.07% or 650,400 shares in its portfolio. Gofen And Glossberg Ltd Liability Il invested 0.02% of its portfolio in Exact Sciences Corporation (NASDAQ:EXAS). Next Century Growth Limited Liability Co has invested 0.94% of its portfolio in Exact Sciences Corporation (NASDAQ:EXAS). Brick And Kyle Associates holds 0.3% or 8,000 shares. Wasatch Inc holds 1% or 1.56M shares in its portfolio. Sandy Spring Bank & Trust invested 0.02% in Exact Sciences Corporation (NASDAQ:EXAS). Adams Diversified Equity Fund Inc invested 0.05% in Exact Sciences Corporation (NASDAQ:EXAS).

ILLEGAL ACTIVITY WARNING: This article was originally reported by The Lincolnian Online and is the sole property of of The Lincolnian Online. Sva Plumb Wealth Management Limited Liability Company stated it has 41,893 shares or 0.24% of all its holdings. Levin Strategies LP invested in 4.21 million shares or 5.19% of the stock. Six analysts have issued estimates for EXACT Sciences' earnings. Great West Life Assurance Can has invested 0% in Exact Sciences Corporation (NASDAQ:EXAS). Eqis Capital Management holds 0.01% or 4,647 shares. 75,683 shares valued at $3.09 million were sold by LIDGARD GRAHAM PETER on Tuesday, September 5. Following the completion of the transaction, the senior vice president now directly owns 37,558 shares in the company, valued at $1,973,297.32. It also reduced its holding in Danaher Corp (NYSE:DHR) by 115,574 shares in the quarter, leaving it with 1.12 million shares, and cut its stake in Lkq Corp (NASDAQ:LKQ).

Since December 8, 2017, it had 13 insider buys, and 0 selling transactions for $12.57 million activity. $13.84 million worth of The Boeing Company (NYSE:BA) was sold by Muilenburg Dennis A on Monday, July 31. WALSH JEFFREY R sold 5,000 shares worth $344,870. 2,522 shares were sold by Verbeck Robert E, worth $616,499. COWARD D SCOTT had sold 1,665 shares worth $87,474.

The company's consensus rating on Reuter's scale remained unchanged from 1.92 to 1.92 during a month. Therefore 65% are positive. Citigroup Inc. had 108 analyst reports since July 21, 2015 according to SRatingsIntel. The company maintains price to book ratio of 12.24 vs.an industry average at 26.34. The firm has "Buy" rating by Canaccord Genuity given on Monday, August 24. C Group Inc Holding A S, a Denmark-based fund reported 153,130 shares. The company was upgraded on Thursday, July 27 by Credit Suisse. The firm has "Buy" rating by Craig Hallum given on Wednesday, July 26. William Blair restated a "buy" rating on shares of EXACT Sciences in a report on Wednesday. The stock is performing 22.38% year to date. The target implies a 7.34% spike from where the shares are now trading. The average analysts gave this company a mean recommendation of 3.00. Over the last five days, shares have managed 0.46% gains and now is up 17.47% since hitting its 200-day moving average of $164.55. BA's profit will be $1.71 billion for 29.09 P/E if the $2.87 EPS becomes a reality. The medical research company reported ($0.23) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.30) by $0.07.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER